Breast cancer staging by subtype in the Lower Mississippi Delta region States

被引:4
作者
Zahnd, Whitney E. [1 ,2 ]
Sherman, Recinda L. [3 ]
Klonoff-Cohen, Hillary [1 ]
McLafferty, Sara L. [4 ]
Farner, Susan [1 ]
Rosenblatt, Karin A. [1 ]
机构
[1] Univ Illinois, Dept Kinesiol & Community Hlth, 1206 S Fourth St, Champaign, IL 61820 USA
[2] Univ South Carolina, Rural & Minor Hlth Res Ctr, Arnold Sch Publ Hlth, 220 Stoneridge Suite 204, Columbia, SC 29210 USA
[3] North Amer Assoc Cent Canc Registries, 2050 W Iles Suite A, Springfield, IL 62704 USA
[4] Univ Illinois, Dept Geog & Geog Informat Sci, 1301 W Green St, Urbana, IL 61801 USA
关键词
Breast cancer; Triple-negative; ER; PR; HER2; Disparities; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; HORMONE-RECEPTOR; DIAGNOSIS; OUTCOMES; RACE/ETHNICITY; EPIDEMIOLOGY; MAMMOGRAPHY; STATISTICS; MORTALITY;
D O I
10.1016/j.canep.2019.101624
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: To evaluate disparities in breast cancer stage by subtype (categorizations of breast cancer based upon molecular characteristics) in the Delta Regional Authority (Delta), an impoverished region across eight Lower Mississippi Delta Region (LMDR) states with a high proportion of Black residents and high breast cancer mortality rates. Methods: We used population-based cancer registry data from seven of the eight LMDR states to explore breast cancer staging (early and late) differences by subtype between the Delta and non-Delta in the LMDR and between White and Black women within the Delta. Age-adjusted incidence rates and rate ratios were calculated to examine regional and racial differences. Multilevel negative binomial regression models were constructed to evaluate how individual-level and area-level factors affect rates of early- and late-stage breast cancers by subtype. Results: For all subtypes combined, there were no Delta/non-Delta differences in early and late stage breast cancers. Delta women had lower rates of hormone-receptor (HR + )/human epidermal growth factor 2 (HER2-) and higher rates of HR-/HER2- (the most aggressive subtype) early and late stage cancers, respectively, but these elevated rates were attenuated in multilevel models. Within the Delta, Black women had higher rates of late-stage breast cancer than White women for most subtypes; elevated late-stage rates of all subtypes combined remained in Black women in multilevel analysis (RR = 1.10; 95% CI = 1.04-1.15). Conclusions: Black women in the Delta had higher rates of late-stage cancers across subtypes. Culturally competent interventions targeting risk-appropriate screening modalities should be scaled up in the Delta to improve early detection.
引用
收藏
页数:8
相关论文
共 50 条
[21]   Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype [J].
Sun, Xuezheng ;
Nichols, Hazel B. ;
Robinson, Whitney ;
Sherman, Mark E. ;
Olshan, Andrew F. ;
Troester, Melissa A. .
CANCER CAUSES & CONTROL, 2015, 26 (12) :1803-1811
[22]   Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development [J].
Saraf, Anurag ;
Grubb, Christopher S. ;
Hwang, Mark E. ;
Tai, Cheng-Hung ;
Wu, Cheng-Chia ;
Jani, Ashish ;
Lapa, Matthew E. ;
Andrews, Jacquelyn I. S. ;
Vanderkelen, Sierra ;
Isaacson, Steven R. ;
Sonabend, Adam M. ;
Sheth, Sameer A. ;
McKhann, Guy M. ;
Sisti, Michael B. ;
Bruce, Jeffrey N. ;
Cheng, Simon K. ;
Connolly, Eileen P. ;
Wang, Tony J. C. .
JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (02) :453-463
[23]   Breast Cancer in Mississippi: Impact of Race and Residential Geographical Setting on Cancer at Initial Diagnosis [J].
Keeton, Kathleen Mechelle ;
Jones, Ellen S. ;
Sebastian, Sunit .
SOUTHERN MEDICAL JOURNAL, 2014, 107 (08) :510-512
[24]   Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer [J].
Chen, Xuesong ;
Sun, Lichun ;
Cong, Yingying ;
Zhang, Tingting ;
Lin, Qiushi ;
Meng, Qingwei ;
Pang, Hui ;
Zhao, Yanbin ;
Li, Yu ;
Cai, Li ;
Dong, Xiaoqun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
[25]   Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer [J].
Xuesong Chen ;
Lichun Sun ;
Yingying Cong ;
Tingting Zhang ;
Qiushi Lin ;
Qingwei Meng ;
Hui Pang ;
Yanbin Zhao ;
Yu Li ;
Li Cai ;
Xiaoqun Dong .
Journal of Experimental & Clinical Cancer Research, 33
[26]   The Influence of Social Determinants on Late Stage Breast Cancer for Women in Mississippi [J].
Fortune, Melody L. .
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2017, 4 (01) :104-111
[27]   Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression [J].
Kroenke, Candyce H. ;
Sweeney, Carol ;
Kwan, Marilyn L. ;
Quesenberry, Charles P. ;
Weltzien, Erin K. ;
Habel, Laurel A. ;
Castillo, Adrienne ;
Bernard, Phillip S. ;
Factor, Rachel E. ;
Kushi, Lawrence H. ;
Caan, Bette J. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (03) :689-699
[28]   Cadmium, Selenium and Breast Cancer Risk by Molecular Subtype Among Women from Northern Mexico [J].
Rojas-Lima, Elodia ;
Rothenberg, Stephen J. ;
Gamboa-Loira, Brenda ;
Merida-Ortega, Angel ;
Cebrian, Mariano E. ;
Lopez-Carrillo, Lizbeth .
EXPOSURE AND HEALTH, 2021, 13 (03) :419-429
[29]   Is Axillary Sonographic Staging Less Accurate in Invasive Lobular Breast Cancer Than in Ductal Breast Cancer? [J].
Sankaye, Prashant ;
Chhatani, Sharmila ;
Porter, Gareth ;
Steel, Jim ;
Doyle, Sarah .
JOURNAL OF ULTRASOUND IN MEDICINE, 2014, 33 (10) :1805-1810
[30]   Epidemiology and clinicopathologic features of breast cancer in China and the United States [J].
Qian, Xiaoyan ;
Zou, Xiaonong ;
Xiu, Meng ;
Liu, Yang ;
Chen, Xi ;
Xiao, Min ;
Zhang, Pin .
TRANSLATIONAL CANCER RESEARCH, 2023, 12 (07) :1826-1835